What does “Orange Book approved drug products” mean?
The FDA’s Orange Book (officially titled Approved Drug Products with Therapeutic Equivalence Evaluations) lists prescription drug products that are approved under the Federal Food, Drug, and Cosmetic Act and includes therapeutic equivalence information. An “Orange Book approved drug product” is a listed, FDA-approved product for which the book provides details such as the active ingredient and whether FDA considers other versions therapeutically equivalent. [1]
What kinds of products appear on the Orange Book?
The Orange Book generally covers FDA-approved “drug products,” including:
- Brand-name (innovator) products
- Generic drug products
- Products with therapeutic equivalence evaluations
The listings are organized in ways that help users find a product by active ingredient, strength, dosage form, and route of administration, and then see the approval and equivalence information associated with that specific product. [1]
How do you find a specific Orange Book approved drug product?
Users typically search by the active ingredient and then refine by:
- Dosage form
- Strength
- Route of administration
That approach matches how the Orange Book is structured for identifying the exact “drug product” entry you need, not just the drug’s name. [1]
What is “therapeutic equivalence” in Orange Book listings?
For many drugs, Orange Book entries include FDA’s therapeutic equivalence determinations (the basis for whether a generic is expected to have the same clinical effect as the reference brand). This is a central reason the Orange Book is used for switching and substitution decisions in clinical practice and pharmacy. [1]
Are Orange Book listings the same as FDA approval?
Yes. If a product is “Orange Book approved,” it means the product is FDA-approved and appears in the Orange Book database. The Orange Book is the public record that compiles approval status plus therapeutic equivalence evaluations for listed products. [1]
Where can I check Orange Book approved products?
The authoritative source is the FDA Orange Book database itself. [1]
DrugPatentWatch.com and Orange Book-type research
If you’re researching patent or exclusivity issues around an Orange Book-listed drug (for example, to understand when generics may enter), DrugPatentWatch.com can be a useful secondary source for patent-related context. [2]
Sources:
[1] https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm
[2] https://www.drugpatentwatch.com/